Highly stomach-selective gene transfer following gastric serosal surface instillation of naked plasmid DNA in rats

Journal of Gastroenterology

Volumn 43, Issue 12, 2008, Pages 912-919

  Nishi, Junya ^a   Fumoto, Shintaro ^a   Ishii, Hiroki ^a   Kodama, Yukinobu ^a   Nakashima, Mikiro ^a   Sasaki, Hitoshi ^b   Nakamura, Junzo ^a   Nishida, Koyo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Gene delivery; Naked plasmid DNA; Rat; Stomach; Targeting

Indexed keywords

LUCIFERASE; NAKED DNA; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; REPORTER GENE; SEROSA; STOMACH MUCOSA; TISSUE LEVEL;

ANIMALS; DNA; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; LUCIFERASES, FIREFLY; MALE; PLASMIDS; RATS; RATS, WISTAR; SEROUS MEMBRANE; STOMACH; TIME FACTORS;

EID: 58149187965     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2301-7     Document Type: Article

References (36)

1. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007;13:470-476.
2. Jones MK, Kawanaka H, Baatar D, Szabó IL, Tsugawa K, Pai R, et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 2001;121:1040-1047.
3. Sutter AP, Fechner H. Gene therapy for gastric cancer: Is it promising? World J Gastroenterol 2006;12:380-387.
4. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346-358.
5. Nishikawa M, Hashida M. Nonviral approaches satisfying various requirements for effective in vivo gene therapy. Biol Pharm Bull 2002;25:275-283.
6. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004;44:203-209.
7. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 2005;50(Suppl 1):S24-S33.
8. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
9. Kawabata K, Takakura Y, Hashida M. The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm Res 1995;12:825-830.
10. Hickman MA, Malone RW, Lehmann-Bruinsma K, Sih TR, Knoell D, Szoka FC, et al. Gene expression following direct injection of DNA into liver. Hum Gene Ther 1994;5:1477-1483.
11. Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000;2:178-187.
12. Lin MTS, Pulkkinen L, Uitto J, Yoon K. The gene gun: Current applications in cutaneous gene therapy. Int J Dermatol 2000;39:161-170.
13. Takehara T, Hayashi N, Yamamoto M, Miyamoto Y, Fusamoto H, Kamada T. In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA. Hum Gene Ther 1996;7:589-593.
14. Chen J, Yang WL, Li G, Qian J, Xue JL, Fu SK, et al. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J Gastroenterol 2004;10:112-116.
15. Kai E, Ochiya T. A method for oral DNA delivery with N -acetylated chitosan. Pharm Res 2004;21:838-843.
16. Kawase M, Hayashi Y, Kinoshita F, Yamato E, Miyazaki J, Yamakawa J, et al. Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine. Biol Pharm Bull 2004;27:2049-2051.
17. Bhavsar MD, Amiji MM. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Control Release 2007;119:339-348.
18. Nishida K, Fujiwara R, Kodama Y, Fumoto S, Mukai T, Nakashima M, et al. Regional delivery of model compounds and 5-fluorouracil to the liver by their application to the liver surface in rats: Its implication for clinical use. Pharm Res 2005;22:1331-1337.
19. Nishida K, Tomiyama N, Mukai T, Nakashima M, Sasaki H, Nakamura J. Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats. Eur J Pharm Biopharm 2004;58:705-711.
20. Nakamura J, Tsurumaru A, Mera K, Mukai T, Nishida K, Sasaki H. Absorption of drugs applied to the gastric serosal surface in rats. Pharm Pharmacol Commun 1999;5:519-522.
21. Mukai T, Tsurumaru A, Mera K, Nishida K, Nakamura J, Sasaki H, et al. Absorption characteristics of model drugs from the gastric serosal surface in rats. Pharm Pharmacol Commun 1999;5:609-614.
22. Nakamura J, Kobayashi K, Fumoto S, Nishi J, Mukai T, Nakashima M, et al. Stomach- and site-selective delivery of 5-fluorouracil following its application on the gastric serosal surface in rats. Biol Pharm Bull 2005;28:1049-1053.
23. Kawakami S, Hirayama R, Shoji K, Kawanami R, Nishida K, Nakashima M, et al. Liver- and lobe-selective gene transfection following the instillation of plasmid DNA to the liver surface in mice. Biochem Biophys Res Commun 2002;294:46-50.
24. Hirayama R, Nishida K, Fumoto S, Nakashima M, Sasaki H, Nakamura J. Unilateral kidney-selective gene transfer following the administration of naked plasmid DNA to the kidney surface in mice. Biol Pharm Bull 2005;28:181-184.
25. Nakamura J, Fumoto S, Shoji K, Kodama Y, Nishi J, Nakashima M, et al. Stomach-selective gene transfer following the administration of naked plasmid DNA onto the gastric serosal surface in mice. Biol Pharm Bull 2006;29:2082-2086.
26. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm Res 2000;17:306-313.
27. Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prêle CM, Laurent GJ, Mutsaers SE. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 2 2002;115:1383-1389.
28. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Suppression of gastric cancer cell growth by targeting the β-catenin/Tcell factor pathway. Cancer 2007;109:188-197.
29. Hirayama R, Kawakami S, Nishida K, Nakashima M, Sasaki H, Sakaeda T, et al. Development of the liver- and lobe-selective nonviral gene transfer following the instillation of naked plasmid DNA using catheter on the liver surface in mice. Pharm Res 2003;20:328-332.
30. Chai J, Baatar D, Tarnawski A. Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 2004;126:1809-1818.
31. Deng X, Szabo S, Khomenko T, Jadus MR, Yoshida M. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 2004;311:982-988.
32. Yang YH, Wu WKK, Tai EKK, Wong HPS, Lam EKY, So WHL, et al. The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats. J Pharmacol Exp Ther 2006;318:547-554.
33. Tanaka T, Huang J, Hirai S, Kuroki M, Kuroki M, Watanabe N, et al. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin Cancer Res 2006;12:3803-3813.
34. Kunisaki R, Ikawa S, Maeda T, Nakazaki Y, Kurita R, Harata M, et al. p51/ p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate. J Gene Med 2006;8:1121-1130.
35. Min Y, Adachi Y, Yamamoto H, Imsumran A, Arimura Y, Endo T, et al. Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts. Gut 2005;54:591-600.
36. Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, et al. RhoA and RhoC-siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. World J Gastroenterol 2007;13:3517-3522.